Medicinal Genomics Revenue and Competitors

Beverly, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Medicinal Genomics's estimated annual revenue is currently $6.7M per year.(i)
  • Medicinal Genomics's estimated revenue per employee is $155,000

Employee Data

  • Medicinal Genomics has 43 Employees.(i)
  • Medicinal Genomics grew their employee count by 10% last year.

Medicinal Genomics's People

NameTitleEmail/Phone
1
Founder, CSOReveal Email/Phone
2
CEOReveal Email/Phone
3
SVP OperationsReveal Email/Phone
4
VP SalesReveal Email/Phone
5
Head Genomics Services/International SalesReveal Email/Phone
6
Director Business Development, CannMed EventsReveal Email/Phone
7
Director Regulatory AffairsReveal Email/Phone
8
Director, CannMed EventsReveal Email/Phone
9
Logistics Manager at Medicinal GenomicsReveal Email/Phone
10
Marketing ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Medicinal Genomics?

Medicinal Genomics is a life sciences company that distributes genetics-based platforms for quality and safety testing of legal cannabis. In addition to our testing platform, we provide services enabling legal cannabis cultivators and distributors to genetically identify cannabis strains so that the medical community can track those cannabis products that provide the maximum patient benefit and product reliability. The MGC Strain ID solution also enables growers to generate the foundational information for documenting and publishing their Intellectual Property for strains they develop. MGC was founded by Kevin McKernan, a world renowned leader in DNA sequencing technology, pioneering researcher and thought leader in cannabis genetics. MGC was the first company to sequence the cannabis genome and has subsequently sequenced hundreds of different cannabis strain genomes. This groundbreaking work has allowed MGC to provide the science for cannabis identification and safety in ways that profoundly enhance the scientific validation of the healing powers of this natural medicine.

keywords:N/A

N/A

Total Funding

43

Number of Employees

$6.7M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Medicinal Genomics News

2022-04-19 - Magic Mushrooms Have Over 80 Different Species—And Their DNA Is Now Available Online - Benzinga

Now, everyone can access Psilocydia, the world's first psilocybin genomic library. What Happened: The site is managed by Medicinal Genomics Corp...

2022-04-17 - Cannabis Testing Equipment Market Size, Share, Growth ...

Cannabis Testing Equipment Market Size, Share, Growth 2022-2029| Key Players – Medicinal Genomics, Hamilton, PerkinElmer, Todaro Robotics.

2022-04-17 - Automated Cannabis Testing Market Growth 2022-2030| Key ...

Automated Cannabis Testing Market Growth 2022-2030| Key Players – Medicinal Genomics, Hamilton, PerkinElmer, Todaro Robotics.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.1M442%N/A
#2
$3.5M44-41%N/A
#3
$9.5M447%N/A
#4
$10.9M472%N/A
#5
$3.8M48-16%N/A